Form D · Biotechnology

Arteaus Therapeutics, LLC

Cambridge, MA · CIK 0001526753

Offering snapshot reported Jul 24, 2012 · SEC filing

Reported sold
$15.6M
Offering amount: $18M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 20, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.8M$15.6MJul 29, 2011: $3,600,000.00Jul 29, 2011Jul 24, 2012: $15,600,000.00Jul 24, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,600,000 → $15,600,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 24, 2012Amendment$15,600,000$12,000,000vs Jul 29, 20113SEC filing
Jul 29, 2011Initial$3,600,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-163669

Source: Form D, filed Jul 24, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jean Francois Formela Director
Jean Francois Fromela Director
David Grayzel Director, Executive
Thomas Schuetz Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
25 First Street Suite 303
Cambridge, MA, 02141